Published 2023 | Version v1
Journal article

Performance of free-breathing dynamic T1-weighted sequences in patients at risk of developing motion artifacts undergoing gadoxetic acid-enhanced liver MRI

  • 1. Department of Radiology, Gachon University Gil Medical Center, 21 Namdong-daero 774 beon-gil, Namdong-gu, 21565, Incheon (Korea, Republic of)
  • 2. Department of Radiology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, 03087, Seoul (Korea, Republic of)
  • 3. Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, 03080, Seoul (Korea, Republic of)
  • 4. Department of Radiology, Inje University Busan Paik Hospital, Bokji-ro 75, Busangjin-gu, 47392, Busan (Korea, Republic of)
  • 5. Department of Radiology, CHA Gangnam Medical Center, CHA University, 566 Nonhyun-ro, Gangnam-gu, 06135, Seoul (Korea, Republic of)
  • 6. MR Application Predevelopment, Siemens Healthcare GmbH, Allee am Roethelheimpark 2, 91052, Erlangen (Germany)
  • 7. Institute of Radiation Medicine, Seoul National University Medical Research Center, 103 Daehak-ro, Jongno-gu, 03087, Seoul (Korea, Republic of)

Description

To evaluate the recall rate and performance of free-breathing T1W dynamic imaging in patients who underwent gadoxetic acid-enhanced liver MRI. We retrospectively reviewed patients who underwent free-breathing dynamic T1WI liver MRI using Cartesian (XD-VIBE) or self-gated radial (SG-GRASP) sequences at two institutions. Four radiologists independently reviewed the overall image quality, streak, and motion artifacts for precontrast, arterial, and portal venous phases on a 4-point scale. Hepatic observations were annotated and assessed according to LI-RADS v2018. In total, 360 patients were included (XD-VIBE [n = 253], SG-GRASP [n = 107]). The overall image quality of free-breathing T1WI was 3.4 ± 0.4, 3.2 ± 0.4, and 3.5 ± 0.4 for precontrast, arterial, and portal venous phases, respectively. The actual recall rate was 0.6% (2/360). The SG-GRASP group showed fewer motion artifacts and more streak artifacts than the XD-VIBE group in all phases (p < 0.001 for all). The overall image quality was not significantly different between the two sequences in arterial (3.2 ± 0.4 in both, p = 0.607) and portal venous phases (3.5 ± 0.4 in XD-VIBE, 3.4 ± 0.4 in SG-GRASP, p = 0.214). Two sequences did not show significant differences in the lesion detection rate (figure of merit, FOM: 0.67 vs. 0.68, p = 0.876) or diagnostic performance for hepatocellular carcinoma (FOM: 0.55 vs. 0.62, p = 0.105). Both XD-VIBE and SG-GRASP provided sufficient image quality for patients at risk of developing motion artifacts, without significant differences in image quality or the lesion detection rate between sequences. The overall image quality of free-breathing T1-weighted images using Cartesian or radial sequences was 3.4 ± 0.4, 3.2 ± 0.4, and 3.5 ± 0.4 for precontrast, arterial, and portal venous phases, respectively. Only 0.3% (1/360) had undiagnostic exams and the actual recall rate was 0.6% (2/360) in patients who underwent free-breathing dynamic T1WI. The overall lesion detection rate was 0.67 without a significant difference between Cartesian and radial sequences (figure of merit: 0.67 vs. 0.68, respectively, p = 0.876).

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00330-022-09336-8

Additional details

Identifiers

Publishing Information

Journal Title
European Radiology (Internet)
Journal Volume
33
Journal Issue
6
Journal Page Range
p. 4378-4388
ISSN
1432-1084
CODEN
EURAE3